SCHEMBL20980415

SCHEMBL20980415

CCC(=O)C(C)C[C@H](CCCCN=[N+]=[N-])NC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22375504 0.89 ALB (0.32) —
SCHEMBL20980404 0.88 — —
SCHEMBL22375760 0.80 ADRB2 (0.31) —
SCHEMBL18880055 0.79 CPB2 (0.34) —
SCHEMBL24420993 0.71 PSMB5 (0.33) —
SCHEMBL18882586 0.71 LMNA (0.30) —
SCHEMBL24012402 0.71 CNR2 (0.32) —
SCHEMBL13539965 0.70 NOS1 (0.40) —
SCHEMBL22375469 0.70 FOLH1 (0.33) —
SCHEMBL20980231 0.70 ADRB2 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200268898-A1 GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF IONIS PHARMACEUTICALS, INC. 2020-08-27 — — US disclosed
US-20190134214-A1 GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof ASTRAZENECA AB (SE) 2019-05-09 — — US disclosed
Send feedback